XENETIC BIOSCIENCES, INC. Capital Expenditures
XENETIC BIOSCIENCES, INC. (XBIO) reported Capital Expenditures of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2019-03-29
- XENETIC BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2018-12-31 was $0.00.
- XENETIC BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2018-09-30 was $0.00.
- XENETIC BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- XENETIC BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- XENETIC BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- XENETIC BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2017 was $9.26K, a 44.83% decline from fiscal 2016.
- XENETIC BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2016 was $16.79K, a 909.80% increase from fiscal 2015.
- XENETIC BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2015 was $1.66K, a 97.12% decline from fiscal 2014.
| Period end | Payments to Acquire Property, Plant, and Equipment 1 month | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 7 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 10 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $0.00 derived: sum of 2 quarters · filed 2019-03-29 | $0.00 derived: sum of 3 quarters · filed 2019-03-29 | $0.00 10-K · filed 2019-03-29 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | $0.00 10-Q · filed 2018-11-09 | $0.00 derived: sum of 4 quarters · filed 2019-03-29 | |||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $0.00 10-Q · filed 2018-08-10 | $0.00 derived: sum of 3 quarters · filed 2019-03-29 | $0.00 derived: sum of 4 quarters · filed 2019-03-29 | |||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-15 | $0.00 derived: sum of 2 quarters · filed 2019-03-29 | $0.00 derived: sum of 3 quarters · filed 2019-03-29 | $3.83K derived: sum of 4 quarters · filed 2019-03-29 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $0.00 derived: sum of 2 quarters · filed 2019-03-29 | $3.83K derived: sum of 3 quarters · filed 2019-03-29 | $9.26K 10-K · filed 2019-03-29 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $3.83K derived: sum of 2 quarters · filed 2018-11-09 | $9.26K 10-Q · filed 2018-11-09 | $11.44K derived: sum of 4 quarters · filed 2018-11-09 | |||
| 2017-06-30 | $3.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $9.26K 10-Q · filed 2018-08-10 | $11.44K derived: sum of 3 quarters · filed 2018-08-10 | $11.44K derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2017-03-31 | $5.43K 10-Q · filed 2018-05-15 | $7.61K derived: sum of 2 quarters · filed 2018-05-15 | $7.61K derived: sum of 3 quarters · filed 2018-05-15 | $7.61K derived: sum of 4 quarters · filed 2018-05-15 | |||
| 2016-12-31 | $2.18K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $2.18K derived: sum of 2 quarters · filed 2018-03-30 | $2.18K derived: sum of 3 quarters · filed 2018-03-30 | $16.79K 10-K · filed 2018-03-30 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $14.61K 10-Q · filed 2017-11-14 | $14.61K derived: sum of 4 quarters · filed 2017-11-14 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $14.61K 10-Q · filed 2017-08-14 | $14.61K derived: sum of 3 quarters · filed 2017-08-14 | $14.61K derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-03-31 | $14.61K 10-Q · filed 2017-05-15 | $14.61K derived: sum of 2 quarters · filed 2017-05-15 | $14.61K derived: sum of 3 quarters · filed 2017-05-15 | $16.28K derived: sum of 4 quarters · filed 2017-05-15 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $0.00 derived: sum of 2 quarters · filed 2017-03-31 | $1.66K derived: sum of 3 quarters · filed 2017-03-31 | $1.66K 10-K · filed 2017-03-31 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $1.66K derived: sum of 2 quarters · filed 2016-11-14 | $1.66K 10-Q · filed 2016-11-14 | $13.32K derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | $1.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $1.66K 10-Q · filed 2016-08-15 | $13.32K derived: sum of 3 quarters · filed 2016-08-15 | $19.75K derived: sum of 4 quarters · filed 2016-08-15 | |||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-16 | $11.66K derived: sum of 2 quarters · filed 2016-05-16 | $18.09K derived: sum of 3 quarters · filed 2016-05-16 | $40.68K derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2014-12-31 | $11.66K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $18.09K derived: sum of 2 quarters · filed 2016-03-30 | $40.68K derived: sum of 3 quarters · filed 2016-03-30 | $57.67K 10-K · filed 2016-03-30 | |||
| 2014-09-30 | $6.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $29.02K derived: sum of 2 quarters · filed 2015-11-16 | $46.01K 10-Q · filed 2015-11-16 | $109.84K derived: sum of 4 quarters · filed 2015-11-16 | |||
| 2014-06-30 | $22.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | $39.58K 10-Q · filed 2015-08-19 | $103.41K derived: sum of 3 quarters · filed 2015-08-19 | ||||
| 2014-03-31 | $16.99K 10-Q · filed 2015-05-20 | $80.82K derived: sum of 2 quarters · filed 2015-07-20 | |||||
| 2013-12-31 | $63.83K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-20 | $78.63K 10-K · filed 2015-07-20 | |||||
| 2013-11-30 | $212.50K 10-Q · filed 2014-01-10 | ||||||
| 2013-09-30 | $4.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $14.80K 10-Q · filed 2014-11-14 | |||||
| 2013-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | $212.50K 10-K · filed 2013-11-27 | |||||
| 2013-06-30 | $5.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $9.83K 10-Q · filed 2014-08-14 | |||||
| 2013-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-07-17 | $212.50K 10-Q · filed 2013-07-17 | |||||
| 2013-03-31 | $4.09K 10-Q · filed 2014-05-20 | ||||||
| 2013-02-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-04-22 | $212.50K 10-Q · filed 2013-04-22 | |||||
| 2012-12-31 | $130.08K 10-K · filed 2015-07-20 | ||||||
| 2012-11-30 | $212.50K 10-Q · filed 2013-01-22 | ||||||
| 2012-05-31 | -$212.50K 10-Q · filed 2012-07-16 | ||||||
| 2012-02-29 | -$212.50K 10-Q · filed 2012-04-24 | ||||||
| 2011-08-31 | $212.50K 10-K · filed 2012-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |